Sections
Pharmaceuticals
Project Groups
Project Group “Clinical Research in Vulnerable Populations”
to the Project GroupProject Group “Potentials and Risks of Psychopharmaceutical Enhancement”
to the Project GroupProject Group “Pharming. Genetically Modified Plants and Animals as Future Production Site of Pharmaceuticals?”
to the Project GroupProject Group “Intervening in the Psyche. Novel Possibilities as Social Challenges”
to the Project Group
Publications
Memorandum “Das optimierte Gehirn. Ein Memorandum zu Chancen und Risiken des Neuroenhancements”, Gehirn&Geist 11/2009, pp. 40-48
Memorandum on website Gehirn&GeistVolume “Intervening in the Brain. Changing Psyche and Society” from the series “Ethics of Science and Technology Assessment” No 29, Springer-Verlag, 2007
to the Springer-Verlag Book SeriesGraue Reihe „Clinical research in minors and the mentally ill”, No 46, 11/2008
to the Graue ReiheFocus “Is there a duty to tolerate research for members of vulnerable populations?”, Newsletter 106/2011
to the NewslettersFocus „The value of authenticity in the age of pharmaceutical neuroenhancement“, Newsletter 80/2008
to the NewslettersFocus ”Research on Minors“, Newsletter 79/2008
to the NewslettersFocus ”Perspectives on Psychopharmacological Enhancement“, Newsletter 73/2007
to the NewslettersFocus ”Pharming – the next step in the debate on gene technology?“, Newsletter 66/2006
to the NewslettersFocus ”Drug effects in combination“, Newsletter 18/2000
to the Newsletters
Events
Public podium discussion on clinical research in vulnerable populations, 10/2011
to the Press Release (German/PDF)
Spring Conference ”Clinical Research in Vulnerable Populations“, 2008
to the Spring ConferenceAutumn Conference ”New Applications of Livestock Genetic Engineering“, 2007
to the Autumn ConferenceExpert Meeting ”Intervening in Psychic Capacities. Neuroscience, Pharmacology, and the Medicalisation of New Spheres of Life“, 05/2003
to the Expert MeetingExpert Meeting ”Pharmacogenomics“, 3/2003
to the Expert Meeting
ea-aw.de